NDC 86032-017-01 - Lapatinib

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 86032-017
Requested NDC: 86032-017-01
Package NDCs from labels: 86032-017-01
Manufacturer: Evereen Shanghai Biotechnology Ltd. | Shandong Boyuan Pharmaceutical Co., Ltd.
Effective date: 2022-11-09
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Lapatinib	Evereen Shanghai Biotechnology Ltd. \| Shandong Boyuan Pharmaceutical Co., Ltd.	2022-11-09	BULK INGREDIENT - ANIMAL DRUG

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYKERB	LAPATINIB	Novartis Pharmaceuticals Corporation	eee37f88-ec6a-4c30-b8aa-e2c71f93088c	2026-01-27	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: LAPATINIB
Lapatinib	LAPATINIB	Lupin Pharmaceuticals, Inc.	50d0dd0c-7682-43d0-aa1b-ca26e9181aee	2025-06-10	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Lapatinib generic name: LAPATINIB
Lapatinib	LAPATINIB	AvKARE	302a4346-a68d-af3e-e063-6294a90a4a6f	2025-03-12	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Lapatinib generic name: LAPATINIB
Lapatinib	LAPATINIB	Teva Pharmaceuticals, Inc.	b09abf73-1eef-4e12-b400-c030d546d223	2023-11-30	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Lapatinib generic name: LAPATINIB

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.